Radiofrequency ablation of pulmonary malignancies

Seminars in Respiratory and Critical Care Medicine

Volumn 29, Issue 4, 2008, Pages 361-383

  Rose, Steven C ^a  

^a UCSD MEDICAL CENTER   (United States)

Author keywords

Image guided therapy; Lung; Lung cancer; Metastases; Radiofrequency ablation

Indexed keywords

EPIDERMAL GROWTH FACTOR; VASCULOTROPIN;

ANTIBIOTIC PROPHYLAXIS; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CARDIOPULMONARY FUNCTION; CELL TYPE; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; FUNCTIONAL STATUS; HUMAN; LUNG CANCER; LUNG LOBECTOMY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; NONHUMAN; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SURVIVAL; TREATMENT RESPONSE; TUMOR VOLUME;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CATHETER ABLATION; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; RADIOGRAPHY, INTERVENTIONAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 48249140217     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1081280     Document Type: Review

References (97)

1. Jemal A, Taylor M, Ward E, et al. Cancer statistics 2005. CA Cancer J Clin 2005;55:10-30
2. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, 1994. CA Cancer J Clin 1994;44:7-26
3. American Cancer Society. Cancer Facts and Figures 2005. Atlanta, GA: American Cancer Society; 2005
4. Mountain CF. A new international staging system for lung cancer. Chest 1986;89(Suppl):225S-233S
5. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-1717
6. Non-Small Cell Lung Cancer (PDQ®): Treatment. Washington, DC: National Cancer Institute, U.S. National Institutes of Health. [www.cancer.gov/cancertopics/PDQ/treatments/non-smallcelllung/patients]
7. Lung. In: American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. New York: Springer; 2002: 167-181
8. Rose SC, Thistlethwaite PA, Sewell PE, Vance RB. Lung cancer and radiofrequency ablation. J Vasc Interv Radiol 2006;17:927-951
9. Figlin RA, Holmes EC, Turrisi AT III. Neoplasms of the lung, pleura, and mediastinum. In: Haskell CM, ed. Cancer Treatment. 4th ed. Philadelphia: WB Saunders; 1995:385-413
10. Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004;350:379-392
11. Burt M, Martini N, Ginsberg RJ. Surgical treatment of lung carcinoma. In: Baue AE, ed. Glenn's Thoracic and Cardiovascular Surgery. 6th ed. Stamford, CT: Appleton & Lange; 1996:421-443
12. Ginsberg RJ, Port JL. Surgical therapy of stage I and non-T3 NO stage II non-small cell lung cancer. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT, Minna JD, eds. Lung Cancer: Principles and Practice. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2000:682-693
13. Ihde DC, Pass HI, Glatstein E. Small cell lung cancer. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer Principles and Practice of Oncology. 5th ed. Philadelphia: Lippincott-Raven; 1997:911-949
14. Deslauriers J. Current surgical treatment of nonsmall cell lung cancer 2001. Eur Respir J Suppl 2002;35:61s-70s
15. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 NO non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg 1995;60:615-623
16. Boysen PG, Block AJ, Moulder PV. Relationship between preoperative pulmonary function tests and complications after thoracotomy. Surg Gynecol Obstet 1981;152:813-815
17. Winton T, Livingston R, Johnson D, et al, for the National Cancer Institute of Canada Clinical Trials Group and the National Cancer Institute of the United States Intergroup JBR. 10 Trial Investigators. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005;352:2589-2597
18. Johnson DH, Fehrenbacher L, Novotny WF, et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 2004;22:2184-2191
19. Sandler A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006;355:2542-2550
20. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leukovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-2342
21. Shepherd FA, Pereira JR, Cinleanu T, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005;353:123-132
22. Willis RA. Secondary tumours of the lungs. In: The Spread of Tumours in the Human Body. London: Butterworth; 1973:167-174
23. Morgan-Parkes JH. Metastases: mechanisms, pathways, and cascades. AJR Am J Roentgenol 1995;164:1075-1082
24. The International Registry of Lung Metastases, Writing Committee: Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997,113:37-49
25. Saito Y, Omiya H, Kohno K, et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: a prognostic assessment. J Thorac Cardiovasc Surg 2002;124:1007-1013
26. Pass HI, Donington JS. Metastatic cancer to the lung. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer. Principles and Practice of Oncology. Philadelphia: Lippincott-Raven; 1997:2536-2551
27. Chen PW, Pass HI. Indications for resection of pulmonary metastases. In: Baue AE. Glenn's Thoracic and Cardiovascular Surgery. 6th ed. Stamford, CT: Appleton & Lange; 1996:499-510
28. Landreneau RJ, De Giacomo T, Mack MJ, et al. Therapeutic video-assisted thoracoscopic surgical resection of colorectal pulmonary metastases. Eur J Cardiothorac Surg 2000;18:671-677
29. Mountain CF, McMurtrey MJ, Hermes KE. Surgery for pulmonary metastasis: a 20-year experience. Ann Thorac Surg 1984;38:323-330
30. Friedel G, Pastorino U, Ginsberg RJ, et al. Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. Eur J Cardiothorac Surg 2002;22:335-344
31. Nahum Goldberg S, Dupuy DE. Image-guided radiofrequency tumor ablation: challenges and opportunities-part I. J Vasc Interv Radiol 2001;12:1021-1032
32. McGahan JP, Browning PD, Brock JM, Tesluk H. Hepatic ablation using radiofrequency electrocautery. Invest Radiol 1990;25:267-270
33. McGahan JP, Brock JM, Tesluk H, Gu WZ, Schneider P, Browning PD. Hepatic ablation with use of radio-frequency electrocautery in the animal model. J Vasc Interv Radiol 1992;3:291-297
34. Kruskal JB, Oliver B, Huertas JC, Goldberg SN. Dynamic intrahepatic flow and cellular alterations during radiofrequency ablation of liver tissue in mice. J Vasc Interv Radiol 2001;12:1193-1201
35. Shirabe K, Takenaka K, Gion T, et al. Analysis of prognostic risk factors in hepatic resection for metastatic colorectal carcinoma with special reference to the surgical margin. Br J Surg 1997;84:1077-1080
36. Elias D, Cavalcanti A, Sabourin JC, et al. Resection of liver metastases from colorectal cancer: the real impact of the surgical margin. Eur J Surg Oncol 1998;24:174-179
37. Dodd GD III, Frank MS, Aribandi M, Chopra S, Chintapalli KN. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. AJR Am J Roentgenol 2001;177:777-782
38. Chen MH, Yang W, Yan K, et al. Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients-mathematic model, overlapping mode, and electrode placement process. Radiology 2004;232:260-271
39. Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE. Percutaneous Image-Guided Thermal Ablation and Radiation Therapy: Outcomes of Combined Treatment for 41 patients with Inoperable Stage I/II Non-Small Cell Lung Cancer. J Vasc Interv Radiol 2006;17:1117-1124
40. Lee JM, Jin GY, Goldberg SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 2004;230:125-134
41. Chin MC, Rosenqvist M, Lee MA, Griffin JC, Langberg JJ. The effect of radiofrequency catheter ablation on permanent pacemakers: an experimental study. Pacing Clin Electrophysiol 1990;13:23-29
42. Tong NY, Ru HJ, Ling HY, Cheung YC, Meng LW, Chung PC. Extracardiac radiofrequency ablation interferes with pacemaker function but does not damage the device. Anesthesiology 2004;100:1041
43. Lencioni R, Crocetti L, Cioni R, Franchini C, Angeletti CA, Bartolozzi C. Radiofrequency ablation of lung tumors: value of multiplanar CT imaging for optimizing treatment protocol. Radiology (p) 2003;229(suppl):548
44. Goldberg SN, Solbiati L, Halpern EF, Gazelle GS. Variables affecting proper system grounding for radiofrequency ablation in an animal model. J Vasc Interv Radiol 2000;11:1069-1075
45. Friedman M, Mikityansky I, Kam A, et al. Radiofrequency ablation of cancer. Cardiovasc Intervent Radiol 2004;27:427-434
46. Ahmed M, Liu Z, Afzal KS, et al. Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology 2004;230:761-767
47. Gadaleta C, Mattioli V, Colucci G, et al. Radiofrequency ablation of 40 lung neoplasms: preliminary results. AJR Am J Roentgenol 2004;183:361-368
48. Bojarski JD, Dupuy DE, Mayo-Smith WW. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR Am J Roentgenol 2005;185:466-471
49. Sewell PE Jr. Percutaneous radiofrequency ablation of primary and secondary pulmonary malignancies using CT guidance. Radiology 2000;217(Suppl P):291
50. Yamamoto A, Nakamura K, Matsuoka T, et al. Radiofrequency ablation in a porcine lung model: correlation between ct and histopathologic findings. AJR Am J Roentgenol 2005;185:1299-1306
51. Sewell PE Jr, Vance RB, Wang YD. Assessing radiofrequency ablation of non-small cell lung cancer with positron emission tomography (PET). Radiology 2000;217(Suppl P):334
52. Akeboshi M, Yamakado K, Nakatsuka A, et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol 2004;15:463-470
53. Goldberg SN, Gazelle GS, Compton CC, McLoud TC. Radiofrequency tissue ablation in the rabbit lung: efficacy and complications. Acad Radiol 1995;2:776-784
54. Morrison PR, van Sonnenberg E, Shankar S, et al. Radiofrequency ablation of thoracic lesions, I: Experiments in the normal porcine thorax. AJR Am J Roentgenol 2005;184:375-380
55. Nomori H, Imazu Y, Watanabe K, et al. Radiofrequency ablation of pulmonary tumors and normal lung tissue in swine and rabbits. Chest 2005;127:973-977
56. Goldberg SN, Gazelle GS, Compton CC, Mueller PR, McLoud TC. Radio-frequency tissue ablation of VX2 tumor nodules in the rabbit lung. Acad Radiol 1996;3:929-935
57. Lee JM, Jin GY, Li CA, et al. Percutaneous radiofrequency thermal ablation of lung VX2 tumors in a rabbit model using a cooled tip-electrode: feasibility, safety, and effectiveness. Invest Radiol 2003;38:129-139
58. Miao Y, Ni Y, Bosmans H, et al. Radiofrequency ablation for eradication of pulmonary tumor in rabbits. J Surg Res 2001;99:265-271
59. Ahrar K, Price RE, Wallace MJ, et al. Percutaneous radiofrequency ablation of lung tumors in a large animal model. J Vasc Interv Radiol 2003;14:1037-1043
60. Tominaga J, Miyachi H, Tekase K, et al. Time-related changes in computed tomographic appearance and pathologic findings after radiofrequency ablation of the rabbit lung: preliminary experimental study. J Vasc Interv Radiol 2005;16:1719-1726
61. Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000;174:57-59
62. Herrera LJ, Fernando HC, Perry Y, et al. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg 2003;125:929-937
63. Suh RD, Wallace AB, Sheehan RE, Heinze SB, Goldin JG. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation-preliminary results. Radiology 2003;229:821-829
64. Steinke K, King J, Glenn D, Morris DL. Radiologic appearance and complications of percutaneous computed tomography-guided radiofrequency-ablated pulmonary metastases from colorectal carcinoma. J Comput Assist Tomogr 2003;27:750-757
65. Yasui K, Kanazawa S, Sano Y, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology 2004;231:850-857
66. Belfiore G, Moggio G, Tedeschi E, et al. CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer - a preliminary report of 33 patients. AJR Am J Roentgenol 2004;183:1003-1011
67. Kang S, Luo R, Liao W, Wu H, Zhang X, Meng Y. Single group study to evaluate the feasibility and complications of radiofrequency ablation and usefulness of post treatment position emission tomography in lung tumours. World J Surg Oncol 2004;2:30
68. Lencioni RA, Crocetti L, Glenn DW, Morris DL, Suh RD, Bartolozzi C. Radiofrequency Ablation of Pulmonary Tumors Responses Evaluation (RAPTURE) trial. Radiology 2004;233(suppl):657
69. VanSonnenberg E, Shankar S, Morrison PR, et al. Radiofrequency ablation of thoracic lesions, II: Initial clinical experience - technical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol 2005;184:381-390
70. Fernando HC, De Hoyos A, Landreneau RJ, et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 2005;129:639-644
71. Mack MG, Luder-Luhr T, Eichler K, Balzer JO, Lehnen T, Vogl TJ. Bipolar radiofrequency ablation of lung metastases. Radiological Society of North America Annual Meeting, Radiology 2005;233(suppl):81
72. Nguyen CL, Scott WJ, Young NA, Rader T, Giles LR, Goldberg M. Radiofrequency Ablation of Primary Lung Cancer: Results from an Ablate and Resect Pilot Study. Chest 2005;128:3507-3511
73. Ambrogi MC, Fontanini G, Cioni R, F'aviana P, Fanucchi O, Mussi A. Biologic effects of radiofrequency thermal ablation on non-small cell lung cancer: results of a pilot study. J Thorac Cardiovasc Surg 2006;131:1002-1006
74. Ambrogi MC, Lucchi M, Dini P, et al. Percutaneous radiofrequency ablation of lung tumours: results in the mid-term. Eur J Cardiothorac Surg 2006:30:177-183
75. Simon CJ, Dupuy DE, Dipetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007;243:268-278
76. Yamakado K, Hase S, Matsuoka T, et al. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol 2007;18:393-398
77. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-216
78. Solbiati L, Goldberg SN, Ierace T, Dellanoce M, Livraghi T, Gazelle GS. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent-early experience. Radiology 1999;211:643-649
79. Raman SS, Lu DS, Vodopich DJ, Savre J, Lassman C. Creation of radiofrequency lesions in a porcine model: correlation with sonography, CT, and histopathology. AJR Am J Roentgenol 2000;175:1253-1258
80. Choi D, Lim HK, Kim SH, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology 2000;217:558-563
81. Chopra S, Dodd GD III, Chintapalli KN, Leyendecker JR, Karahan OI, Rhim H. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT. AJR Am J Roentgenol 2001;177:381-387
82. Cioni D, Lencioni R, Rossi S, et al. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power Doppler sonography to assess treatment outcome. AJR Am J Roentgenol 2001;177:783-788
83. Meloni MF, Goldberg SN, Livraghi T, et al. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. AJR Am J Roentgenol 2001;177:375-380
84. Kim SK, Lim HK, Kim YH, et al. Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings. Radiographics 2003;23:107-121
85. Morimoto M, Nozawa A, Numata K, et al. Evaluation using contrast-enhanced harmonic gray scale sonography after radio frequency ablation of small hepatocellular carcinoma: sonographic-histopathologic correlation. J Ultrasound Med 2005;24:273-283
86. Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 2003;14(9 Pt 2):S199-S202
87. Yamagami T, Kato T, Hirota T, Yoshimatsu R, Matsumoto T, Nishimura T. Pneumothorax as a complication of percutaneous radiofrequency ablation for lung neoplasms. J Vasc Interv Radiol 2006;17:1625-1629
88. Hiraki T, Tajiri N, Mimura H, et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors; incidence and risk factors. Radiology 2006;241:275-283
89. Jin GY, Lee JM, Lee YC, Han YM. Acute cerebral infarction after radiofrequency ablation of an atypical carcinoid pulmonary tumor. AJR Am J Roentgenol 2004;182:990-992
90. Yamakado K, Akeboshi M, Nakatsuka A, et al. Tumor seeding following lung radiofrequency ablation: a case report. Cardiovasc Intervent Radiol 2005;28:530-532
91. Steinke K, King J, Glenn DW, Morris DL. Percutaneous radiofrequency ablation of lung tumors with expandable needle electrodes: tips from preliminary experience. AJR Am J Roentgenol 2004;183:605-611
92. Kinney TB, Chen HT, Rose SC, Valji K, Roberts AC. Complications of thoracic intervention: evaluation of contributory factors. J Vasc Interv Radiol 2003;14(Suppl):S89
93. Okuma T, Matsuoka T, Yamamoto A, et al. Factors contributing to cavitation after CT-guided percutaneous radiofrequency ablation for lung tumors. J Vasc Interv Radiol 2007;18:399-404
94. Hiraki T, Yasui K, Mimura H, et al. Radiofrequency ablation of metastatic mediastinal lymph nodes during cooling and temperature monitoring of the tracheal mucosa to prevent thermal tracheal damage: initial experience. Radiology 2005;237:1068-1074
95. Rose SC, Fotoohi M, Levin DL, Harrell JH. Cerebral microembolization during radiofrequency ablation of lung malignancies. J Vasc Interv Radiol 2002;13:1051-1054
96. Yamamoto A, Matsuoka T, Toyoshima M, et al. Assessment of cerebral microembolism during percutaneous radiofrequency ablation of lung tumors using diffusion-weighted imaging. AJR Am J Roentgenol 2004;183:1785-1789
97. Ahrar K, Stafford RJ, Tinkey PT, et al. Evaluation of cerebral microemboli during radiofrequency ablation of lung tumors in a canine model with use of impedance-controlled devices. J Vasc Interv Radiol 2007;18:929-935